XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Stock-Based Compensation Expense The following table presents stock-based compensation expense in the Company’s consolidated statements of comprehensive income:

 

 

 

For the Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cost of product revenue

 

$

1,933

 

 

$

2,525

 

 

$

2,021

 

Research and development

 

 

2,855

 

 

 

2,622

 

 

 

2,856

 

Selling, general and administrative

 

 

20,787

 

 

 

22,169

 

 

 

22,623

 

Total stock-based compensation

 

$

25,575

 

 

$

27,316

 

 

$

27,500

 

Estimated Weighted Average Assumptions

The fair value of stock option awards granted during the years ended December 31, 2023, 2022 and 2021 were calculated using the following estimated assumptions:

 

 

 

For the Years Ended December 31,

 

 

2023

 

2022

 

2021

Expected term (in years)

 

5.14-6.5

 

5.5-6.5

 

5.5-6.5

Expected volatility (range)

 

44.78-46.58%

 

41.44-43.96%

 

44.57-45.27%

Risk-free interest rate

 

3.56-4.71%

 

1.86-4.07%

 

0.77-1.07%

Expected dividend yield

 

0%

 

0%

 

0%

Summary of Option Activity

Information regarding option activity for the year ended December 31, 2023, under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted
average
exercise
price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value
(in Thousands)

 

Options outstanding at December 31, 2022

 

 

609,965

 

 

$

71.74

 

 

 

 

 

 

 

Granted

 

 

90,305

 

 

$

168.22

 

 

 

 

 

 

 

Exercised

 

 

(40,211

)

 

$

26.76

 

 

 

 

 

 

 

Forfeited/expired/cancelled

 

 

(10,929

)

 

$

189.46

 

 

 

 

 

 

 

Options outstanding at December 31, 2023

 

 

649,130

 

 

$

85.97

 

 

 

 

 

 

 

Options exercisable at December 31, 2023

 

 

364,443

 

 

$

65.53

 

 

 

 

 

 

 

Vested and expected to vest at December 31, 2023(1)

 

 

635,834

 

 

$

85.49

 

 

 

5.59

 

 

$

61,888

 

 

(1)
Represents the number of vested options as of December 31, 2023 plus the number of unvested options expected to vest as of December 31, 2023, based on the unvested outstanding options at December 31, 2023 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.
Summary of Restricted Stock Unit Activity Information regarding stock unit activity, which includes activity for restricted stock units and performance stock units, for the year ended December 31, 2023 under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted Average
Grant Date
Fair Value

 

 

Unvested at December 31, 2022

 

 

531,034

 

 

$

142.57

 

 

Awarded

 

 

212,338

 

 

$

170.03

 

 

Vested

 

 

(195,672

)

 

$

124.58

 

 

Forfeited/cancelled

 

 

(73,380

)

 

$

177.81

 

 

Unvested at December 31, 2023

 

 

474,320

 

 

$

155.59

 

 

Vested and expected to vest at December 31, 2023(1)

 

 

413,249

 

 

$

152.74

 

 

 

(1)
Represents the number of vested stock units as of December 31, 2023, plus the number of unvested stock units expected to vest as of December 31, 2023, based on the unvested outstanding stock units at December 31, 2023 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.